At Crown Bioscience, we are focused on discovering and validating PD, surrogate, and predictive biomarkers that can differentiate between responders and non-responders in a patient population.
Understand the relationships between genes, protein expression, molecular interactions and activity that define the fundamental components of a predictive biomarkers.
De-risk your therapeutic development through early identification of candidate biomarkers and clinical evaluation of companion diagnostics.
Identify responders, partial responders and non-responders with mouse clinical trials to help stratify patients before you enter the clinic.
Explore a proprietary genetic signature discovery and validation platform, allowing higher identification probability of response to your molecule.
